ProCE Banner Activity

CE

Addressing the Gaps and Clinical Challenges in irAE Management: Updates and Strategies for Oncology Pharmacists

Clinical Thought

Explore these practical tips on recognizing, monitoring, and managing immune-related adverse events associated with immune checkpoint inhibitors. Experts discuss clinical pearls on proactive interventions to minimize toxicity severity and maintain cancer treatment continuity.

Pharmacists: 0.25 contact hour (0.025 CEUs)

Released: January 29, 2025

Expiration: January 28, 2026

Share

Provided by

Provided by ProCE, LLC in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck Sharp & Dohme LLC, Rahway, NJ, USA

Partners

Clinical Care Options, LLC

ProCE Banner

Target Audience

The target audience for this activity is pharmacists, including community, outpatient, and ambulatory care pharmacists, who care for patients with and at risk for irAEs.

Program Learning Goal

This activity aims to improve pharmacists’ knowledge and competence in identifying and managing irAEs, which will improve patient outcomes.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize the clinical efficacy and safety profiles associated with ICIs and ICI-targeted therapy combinations in various types of cancers

  • Develop a proactive management plan for early recognition and appropriate management of irAEs associated with ICI and ICI-targeted therapy combinations encompassing quality of life considerations, treatment adherence and persistence, and collaboration among the multidisciplinary cancer care team

  • Differentiate between immune-related and targeted therapy-associated adverse events to identify proper management approaches

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Alexa Basilio, PharmD, BCOP

Oncology Pharmacy Specialist
McKesson, The US Oncology Network
Tampa, Florida

Alexa Basilio, PharmD, BCOP, has no relevant financial relationships to disclose.

Jessica Davis, PharmD, BCOP, CPP

Clinical Pharmacist Coordinator, Adult Hematology/Oncology
Atrium Health Levine Cancer
Charlotte, North Carolina

Jessica Davis, PharmD, BCOP, CPP: consultant/advisor/speaker: Bristol Myers Squibb.

The planners and content peer reviewers from ProCE, LLC, and Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Nicolle Rochino, PharmD, RPh, as noted below.

Nicolle Rochino, PharmD, RPh: employee (relationship has ended): Novo Nordisk.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 29, 2025, through January 28, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Pharmacists

This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-25-001-H01-P has been assigned to this home study knowledge-based activity. This activity is approved for 0.25 contact hours (0.025 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.